摘要
2型糖尿病患病率高,伴发情绪障碍发病率亦高于非糖尿病人群,其情绪障碍主要以焦虑、抑郁障碍为主。糖尿病与情绪障碍间相互影响,存在一定关联,对患者生存质量造成较大影响。其治疗包括药物和非药物治疗,抗焦虑药物主要包括苯二氮卓类和非苯二氮卓类,抗抑郁药物主要包括单胺氧化酶抑制剂,单胺类神经递质再摄取抑制剂:三环类抗抑郁药、5-羟色胺-去甲肾上腺素再摄取抑制剂、选择性5-羟色胺再摄取抑制剂、选择性去甲肾上腺素再摄取抑制剂以及中草药。非药物治疗包括糖尿病知识教育、心理支持、行为干预等,但其统一与规范尚待进一步完善。
The prevalence of type 2 diabetes mellitus is high, and the incidence of mood disorder, mainly including anxiety and depression, is higher than that of non-diabetics. There is a certain correlation between mood disorders and diabetes mellitus, which has a considerable impact on patients＇ quality of life. The treatments include drug and non-drug therapy, and the anti-anxiety agents mainly include benzodiazepines and non-benzodiazepines. Antidepressant drugs mainly include monoamine oxidase inhibitors, monoamine neurotransmitter reuptake inhibitors, tricyclic antidepressants, 5-serotonin norepinephrine reuptake inhibitors ,5-selective serotonin reuptake inhibitors,selective norepinephrine reuptake inhibitors and Chinese herbal medicine. Non-drug therapy includes the education of diabetes knowledge, psychological support, the intervention of behavior and so on, which need further unification and specification.
出处
《医学综述》
2017年第10期2002-2006,共5页
Medical Recapitulate
关键词
2型糖尿病
情绪障碍
药物治疗
非药物治疗
Type 2 diabetes mellitus
Mood disorders
Drug therapy
Non-drug therapy
